Anzeige
Erschienen in:
01.06.2014 | Author Disclosure Summary
Japanese Society of Gastroenterological Surgery Article Series Disclosure Index
Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2014
Einloggen, um Zugang zu erhaltenExcerpt
The Annals of Surgical Oncology ensures balance, independence, objectivity, and scientific rigor in all its published articles. Authors are expected to disclose any significant financial interest or other relationship(s) involving themselves with any proprietary entity producing health care goods or services related to the content of the article (Table 1).
Table 1
Disclosure index for Japanese Society of Gastroenterological Surgery article series
|
Article title
|
Lead author
|
Disclosure
|
|---|---|---|
|
Usefulness of Contrast-Enhanced Intraoperative Ultrasound in Identifying Disappearing Liver Metastases from Colorectal Carcinoma After Chemotherapy
|
Junichi Arita, MD, PhD
|
Disclosure. Junichi Arita, Yoshihiro Ono, Michiro Takahashi, Yosuke Inoue, Yu Takahashi, and Akio Saiura have no commercial interest in the subject of study and the source of any financial or material support
|
|
Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival
|
Toru Beppu, MD, PhD, FACS
|
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
|
|
Quality of Surgery for Stage III Colon Cancer: Comparison Between England, Germany, and Japan
|
Hirotoshi Kobayashi, MD
|
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
|
|
Pulmonary Metastasectomy Secondary to Esophageal Carcinoma: Long-Term Survival and Prognostic Factors
|
Nao Kobayashi, MD
|
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
|
|
Comparison of the Therapeutic Outcomes Between Surgical Resection and Percutaneous Ablation for Small Hepatocellular Carcinoma
|
Kiyoshi Hasegawa, MD, PhD
|
Disclosure. Kiyoshi Hasegawa, Taku Aoki, Takeaki Ishizawa, Junichi Kaneko, Yoshihiro Sakamoto, Yasuhiko Sugawara, and Nor- ihiro Kokudo have no conflicts of interest and nothing to disclose
|
|
Long-Term Clinical and Functional Results of Intersphincteric Resection for Lower Rectal Cancer
|
Motoi Koyama, MD
|
Disclosure. This study received no financial support
|
|
Profiling of Autoantibodies in Sera of Pancreatic Cancer Patients
|
Yosuke Nagayoshi, MD
|
Disclosure. Yosuke Nagayoshi, Masafumi Nakamura, Kazu- hiro Matsuoka, Takao Ohtsuka, Yasuhisa Mori, Hiroshi Kono, Teppei Aso, Noboru Ideno, Shunichi Takahata, Akihide Ryo, Hiroyuki Takeda, Tetsuhide Ito, Yoshinao Oda, Yaeta Endo, Tatsuya Sawasaki, and Masao Tanaka have no conflicts of interest directly relevant to the content of this article
|
|
Expression Analysis of THOP1 in Background Liver, a Prognostic Predictive Factor in Hepatocellular Carcinoma, Extracted by Multiarray Analysis
|
Shuji Nomoto, MD, PhD
|
Disclosure. There are no disclosures from any authors
|
|
Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy
|
Shinichiro Yamada, MD
|
Disclosure. Shinichiro Yamada and co-authors have no financial interest linked to this work
|
|
CD8+ and FOXP3+ Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer
|
Eiji Shinto, MD
|
Disclosure. This work was supported in part by the National Cancer Center Research and Development Fund (23-A-11 and 23-A-26) and by Japan Society for the Promotion of Science KAKENHI (23501302 and 25462074). We certify that we do not have any commercial associations that may pose a conflict of interest in connection with this article
|
|
Preoperative Evaluation of Venous Anatomy in Laparoscopic Complete Mesocolic Excision for Right Colon Cancer
|
Takayuki Ogino, MD
|
Disclosure. Takayuki Ogino, Ichiro Takemasa, Genki Horitsugi, Mamoru Furuyashiki, Katsuya Ohta, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Tsunekazu Mizushima, Hirofumi Yamamoto, Yuichiro Doki, and Masaki Mori have no conflicts of interest or financial ties to disclose
|
|
EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma
|
Tatsuo Matsuda, MD
|
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
|
|
Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and Changes in Body Weight are Useful Tools for Evaluation of Reconstruction Methods Following Distal Gastrectomy
|
Masanori Terashima, MD, PhD, FACS
|
Disclosure. The authors declare no conflicts of interest with regard to this manuscript
|
|
Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
|
Shun-ichi Ariizumi, MD
|
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
|
|
Is Preoperative Colonoscopy Necessary for Patients Undergoing Gastric Cancer Surgery?
|
Toshiyasu Ojima, MD
|
Disclosure. All authors have nothing to declare
|
|
Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study
|
Takaki Yoshikawa, MD, PhD
|
Disclosure. The authors have not declared any commercial interests related to the subject of the study nor that the study received any external financial or material support
|